Clinical Use of Interferon-gamma
- PMID: 20074276
- PMCID: PMC6574079
- DOI: 10.1111/j.1749-6632.2009.05069.x
Clinical Use of Interferon-gamma
Abstract
Interferon gamma (IFN-gamma), a pleotropic cytokine, has been shown to be important to the function of virtually all immune cells and both innate and adaptive immune responses. In 1986, early clinical trials of this cytokine began to evaluate its therapeutic potential. The initial studies focused on the tolerability and pharmacology of IFN-gamma and systematically determined its antitumor and anti-infection activities. In the 20-plus years since those first trials, IFN-gamma has been used in a wide variety of clinical indications, which are reviewed in this article.
Conflict of interest statement
Conflicts of Interest
The authors declare no conflicts of interest.
Similar articles
-
Interferon-γ and systemic autoimmunity.Discov Med. 2013 Sep;16(87):123-31. Discov Med. 2013. PMID: 23998448 Free PMC article. Review.
-
CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.mBio. 2014 Oct 21;5(5):e01978-14. doi: 10.1128/mBio.01978-14. mBio. 2014. PMID: 25336459 Free PMC article.
-
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):207. PMID: 17051976 Retracted. Review.
-
Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.J Virol. 2017 Sep 12;91(19):e01042-17. doi: 10.1128/JVI.01042-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28747505 Free PMC article.
-
Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).Clin Ter. 2006 Sep-Oct;157(5):457-68. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):208. PMID: 17147054 Retracted. Review.
Cited by
-
IFNγ producing CD8+ T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas.Oncoimmunology. 2015 Mar 6;4(2):e974959. doi: 10.4161/2162402X.2014.974959. eCollection 2015 Feb. Oncoimmunology. 2015. PMID: 25949872 Free PMC article.
-
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.Front Immunol. 2020 Sep 17;11:2177. doi: 10.3389/fimmu.2020.02177. eCollection 2020. Front Immunol. 2020. PMID: 33072081 Free PMC article. Review.
-
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.Oncotarget. 2016 Jul 5;7(27):41053-41066. doi: 10.18632/oncotarget.9419. Oncotarget. 2016. PMID: 27203391 Free PMC article.
-
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management.J Pers Med. 2021 Oct 27;11(11):1102. doi: 10.3390/jpm11111102. J Pers Med. 2021. PMID: 34834454 Free PMC article. Review.
-
Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.Hum Genet. 2012 Feb;131(2):289-99. doi: 10.1007/s00439-011-1076-8. Epub 2011 Aug 5. Hum Genet. 2012. PMID: 21818580 Free PMC article.
References
-
- Young HA, Romero-Weaver AL, Savan R, et al. 2007. Interferon-gamma. Interferon-γ in Class II Cytokines Zdanov A, Ed.: 51–106. Research Signpost, Kerala, India.
-
- Jaffe HS & Sherwin SA. 1986. The early clinical trials of recombinant human interferon-gamma. Interferons as Cell Growth Inhibitors and Antitumor Factors Freedman R, Merigan T & Sreevalson T, Eds.: 37–46. Alan R. Liss; New York.
-
- Condos R, Hull FP, Schluger NW, et al. 2004. Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis. Chest 125: 2146–2155. - PubMed
-
- Soza A, Heller T, Ghany M, et al. 2005. Pilot study of interferon gamma for chronic hepatitis C. J. Hepatol 43: 67–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources